153 related articles for article (PubMed ID: 19101989)
1. Effects of sunitinib on tumor hemodynamics and delivery of chemotherapy.
Czabanka M; Vinci M; Heppner F; Ullrich A; Vajkoczy P
Int J Cancer; 2009 Mar; 124(6):1293-300. PubMed ID: 19101989
[TBL] [Abstract][Full Text] [Related]
2. Antiangiogenic and anti-invasive effects of sunitinib on experimental human glioblastoma.
de Boüard S; Herlin P; Christensen JG; Lemoisson E; Gauduchon P; Raymond E; Guillamo JS
Neuro Oncol; 2007 Oct; 9(4):412-23. PubMed ID: 17622648
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of tumor growth, angiogenesis, and microcirculation by the novel Flk-1 inhibitor SU5416 as assessed by intravital multi-fluorescence videomicroscopy.
Vajkoczy P; Menger MD; Vollmar B; Schilling L; Schmiedek P; Hirth KP; Ullrich A; Fong TA
Neoplasia; 1999 Apr; 1(1):31-41. PubMed ID: 10935468
[TBL] [Abstract][Full Text] [Related]
4. Sunitinib inhibits tumor growth and synergizes with cisplatin in orthotopic models of cisplatin-sensitive and cisplatin-resistant human testicular germ cell tumors.
Castillo-Avila W; Piulats JM; Garcia Del Muro X; Vidal A; Condom E; Casanovas O; Mora J; Germà JR; Capellà G; Villanueva A; Viñals F
Clin Cancer Res; 2009 May; 15(10):3384-95. PubMed ID: 19417025
[TBL] [Abstract][Full Text] [Related]
5. Irradiation combined with SU5416: microvascular changes and growth delay in a human xenograft glioblastoma tumor line.
Schuuring J; Bussink J; Bernsen HJ; Peeters W; van Der Kogel AJ
Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):529-34. PubMed ID: 15667976
[TBL] [Abstract][Full Text] [Related]
6. Antiangiogenic therapy inhibits the recruitment of vascular accessory cells to the perivascular niche in glioma angiogenesis.
Parmaksız G; Czabanka M; Vinci M; Vajkoczy P
J Vasc Res; 2014; 51(2):102-9. PubMed ID: 24556643
[TBL] [Abstract][Full Text] [Related]
7. Sunitinib: from rational design to clinical efficacy.
Chow LQ; Eckhardt SG
J Clin Oncol; 2007 Mar; 25(7):884-96. PubMed ID: 17327610
[TBL] [Abstract][Full Text] [Related]
8. Combined inhibition of vascular endothelial growth factor and platelet-derived growth factor signaling: effects on the angiogenesis, microcirculation, and growth of orthotopic malignant gliomas.
Farhadi MR; Capelle HH; Erber R; Ullrich A; Vajkoczy P
J Neurosurg; 2005 Feb; 102(2):363-70. PubMed ID: 15739567
[TBL] [Abstract][Full Text] [Related]
9. The brain-penetrating CXCR4 antagonist, PRX177561, increases the antitumor effects of bevacizumab and sunitinib in preclinical models of human glioblastoma.
Gravina GL; Mancini A; Marampon F; Colapietro A; Delle Monache S; Sferra R; Vitale F; Richardson PJ; Patient L; Burbidge S; Festuccia C
J Hematol Oncol; 2017 Jan; 10(1):5. PubMed ID: 28057017
[TBL] [Abstract][Full Text] [Related]
10. Antiangiogenic agents targeting different angiogenic pathways have opposite effects on tumor hypoxia in R-18 human melanoma xenografts.
Gaustad JV; Simonsen TG; Andersen LMK; Rofstad EK
BMC Cancer; 2017 Jun; 17(1):411. PubMed ID: 28606060
[TBL] [Abstract][Full Text] [Related]
11. Combined effect of vascular-leakage-blocker Sac-1004 and antiangiogenic drug sunitinib on tumor angiogenesis.
Lee K; Agrawal V; Kim K; Kim J; Park H; Lee S; Kim YM; Suh YG; Kwon YG
Biochem Biophys Res Commun; 2014 Aug; 450(4):1320-6. PubMed ID: 25003323
[TBL] [Abstract][Full Text] [Related]
12. Monitoring tumor response to antiangiogenic sunitinib therapy with 18F-fluciclatide, an 18F-labeled αVbeta3-integrin and αV beta5-integrin imaging agent.
Battle MR; Goggi JL; Allen L; Barnett J; Morrison MS
J Nucl Med; 2011 Mar; 52(3):424-30. PubMed ID: 21321268
[TBL] [Abstract][Full Text] [Related]
13. Intravital microscopy reveals novel antivascular and antitumor effects of endostatin delivered locally by alginate-encapsulated cells.
Read TA; Farhadi M; Bjerkvig R; Olsen BR; Rokstad AM; Huszthy PC; Vajkoczy P
Cancer Res; 2001 Sep; 61(18):6830-7. PubMed ID: 11559558
[TBL] [Abstract][Full Text] [Related]
14. Combined therapy with direct and indirect angiogenesis inhibition results in enhanced antiangiogenic and antitumor effects.
Abdollahi A; Lipson KE; Sckell A; Zieher H; Klenke F; Poerschke D; Roth A; Han X; Krix M; Bischof M; Hahnfeldt P; Grone HJ; Debus J; Hlatky L; Huber PE
Cancer Res; 2003 Dec; 63(24):8890-8. PubMed ID: 14695206
[TBL] [Abstract][Full Text] [Related]
15. Vascular disruptive agent OXi4503 and anti-angiogenic agent Sunitinib combination treatment prolong survival of mice with CRC liver metastasis.
Nguyen L; Fifis T; Christophi C
BMC Cancer; 2016 Jul; 16():533. PubMed ID: 27460820
[TBL] [Abstract][Full Text] [Related]
16. Antiangiogenic agent sunitinib transiently increases tumor oxygenation and suppresses cycling hypoxia.
Matsumoto S; Batra S; Saito K; Yasui H; Choudhuri R; Gadisetti C; Subramanian S; Devasahayam N; Munasinghe JP; Mitchell JB; Krishna MC
Cancer Res; 2011 Oct; 71(20):6350-9. PubMed ID: 21878530
[TBL] [Abstract][Full Text] [Related]
17. MRI biomarkers identify the differential response of glioblastoma multiforme to anti-angiogenic therapy.
Jalali S; Chung C; Foltz W; Burrell K; Singh S; Hill R; Zadeh G
Neuro Oncol; 2014 Jun; 16(6):868-79. PubMed ID: 24759636
[TBL] [Abstract][Full Text] [Related]
18. Antitumor effects of sunitinib or sorafenib in patients with metastatic renal cell carcinoma who received prior antiangiogenic therapy.
Tamaskar I; Garcia JA; Elson P; Wood L; Mekhail T; Dreicer R; Rini BI; Bukowski RM
J Urol; 2008 Jan; 179(1):81-6; discussion 86. PubMed ID: 17997441
[TBL] [Abstract][Full Text] [Related]
19. Ageing-related responses to antiangiogenic effects of sunitinib in atherosclerosis-prone mice.
Meehan B; Garnier D; Dombrovsky A; Lau K; D'Asti E; Magnus N; Rak J
Mech Ageing Dev; 2014 Sep; 140():13-22. PubMed ID: 25068886
[TBL] [Abstract][Full Text] [Related]
20. Differential effect of sunitinib on the distribution of temozolomide in an orthotopic glioma model.
Zhou Q; Gallo JM
Neuro Oncol; 2009 Jun; 11(3):301-10. PubMed ID: 18971416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
